revealed in their investigations that mitochondrial APE1 may promote the resistance to Cisplatin, a well‐known cancer chemotherapeutic agent, by down‐regulating reactive oxygen species in osteosarcoma.34, 35. This evidence concerns the gene APEX1 and cancer.